Probiotics in women’s health
The human probiotics market size is anticipated to surpass USD 5 billion by 2024 owing to its increasing demand. Probiotics are used to treat Urinary tract infections, diabetes, diarrhea, vulvovaginal candidiasis, and bacterial vaginosis in women. Several in vitro and in vivo studies support the beneficial effect of some strains of lactobacilli on the restoration of the vaginal flora and the prevention of recurrent UTIs.
Related Conference of Probiotics in women’s health
August 13-14, 2024
10th International Congress on Trauma, Critical Care and Emergency Medicine
Amsterdam, Netherlands
September 26-27, 2024
19th International Conference on Virology, Emerging Diseases & vaccines
Montreal, Canada
October 24-25, 2024
9th International Conference on Molecular Medicine and Diagnostics
Zurich, Switzerland
November 25-26, 2024
8th International Conference on Microbiome, Probiotics & Gut Nutrition
London, UK
December 02-03, 2024
7th International Conference on Antimicrobial and Antibacterial Agents
Prague, Czech Republic
December 02-03, 2024
7th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Prague, Czech Republic
Probiotics in women’s health Conference Speakers
Recommended Sessions
- Microbiome
- Pediatric and Infant Health
- Pre and Probiotics futures
- Prebiotics and Diet
- Prebiotics old and new
- Probiotics in Aquaculture
- Probiotics in food security
- Synbiotic
- Food and Fermentation
- Formulations and Production
- Gut Bacteria on COVID Severity
- Gut microbiota
- Microbiota from womb to adult
- Microbiota Protection and Resilience
- New Methods and New Equipment
- Nutrition and Probiotics
- Preterm and term Newborns Probiotics
- Probiotics and COVID-19
- Probiotics in oral health and dentistry
- Probiotics in women’s health
Related Journals
Are you interested in
- 16S sequencing & Analysis - Microbiome 2024 (UK)
- Agriculture Microbiology - Beneficial Microbes 2024 (Ireland)
- Animals in a bacterial world, a new imperative for the life sciences - Microbiome 2024 (UK)
- Antimicrobial Use in Veterinary Medicine - Antimicrobial Congress 2024 (Czech Republic)
- Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Antiviral Therapies and Drug Development - Antimicrobial Congress 2024 (Czech Republic)
- Arbuscular Mycorrhizal Fungi [AMF] - Microbiome 2024 (UK)
- Beneficial Microbes in the environment - Beneficial Microbes 2024 (Ireland)
- Benefits Of Bio stimulants - Microbiome 2024 (UK)
- Bioinformatics for Microbiome - Microbiome 2024 (UK)
- Biological Need of Trauma - TRAUMA 2024 (Netherlands)
- Biostimulants and Biocontrol strategies - Microbiome 2024 (UK)
- Blunt Trauma - TRAUMA 2024 (Netherlands)
- Clinical and Neuro Virology - Virology-2024 (Canada)
- Combination Therapy for Antimicrobial Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Corona Virus - Virology-2024 (Canada)
- Critical Care in Trauma - TRAUMA 2024 (Netherlands)
- Delirium in Critical Care - TRAUMA 2024 (Netherlands)
- Drug-Resistant Bacteria: Challenges and Solutions - Antimicrobial Congress 2024 (Czech Republic)
- Ecology and Evolution of Microbe-Host Interactions - Beneficial Microbes 2024 (Ireland)
- Elderly Trauma and Critical Care - TRAUMA 2024 (Netherlands)
- Engineering Beneficial Microbes - Beneficial Microbes 2024 (Ireland)
- Evolution in Emergency Medicine Practices - TRAUMA 2024 (Netherlands)
- General Virology - Virology-2024 (Canada)
- Gut Micro biota - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- HIV/AIDS and Sexually Transmitted Infections - Virology-2024 (Canada)
- Horticulture Hydroponics - Microbiome 2024 (UK)
- Host-Microbe Biology (HMB) - Microbiome 2024 (UK)
- Human Micro biota - Microbiome 2024 (UK)
- Immunization and Immunotherapeutics - Virology-2024 (Canada)
- Immunobiotics - Beneficial Microbes 2024 (Ireland)
- Influenza and other Respiratory Diseases - Virology-2024 (Canada)
- Intensive Care in Trauma - TRAUMA 2024 (Netherlands)
- Interplay between diet, gut micro biota, epigenetic events, and colorectal cancer - Microbiome 2024 (UK)
- Marine Microbiology - Beneficial Microbes 2024 (Ireland)
- Mechanisms of Antibiotic Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Micro biota in early life shapes the immune system - Microbiome 2024 (UK)
- Microbial Infections - Virology-2024 (Canada)
- Microbiome - Beneficial Microbes 2024 (Ireland)
- Microbiome - Microbiome 2024 (UK)
- Microbiome as a human organ - Microbiome 2024 (UK)
- Microbiome: Science comes to life - Microbiome 2024 (UK)
- Modulation of Micro biota - Microbiome 2024 (UK)
- Nanotechnology in Antimicrobial Drug Delivery - Antimicrobial Congress 2024 (Czech Republic)
- New and Endogenous Retroviruses - Virology-2024 (Canada)
- New Technology in Trauma - TRAUMA 2024 (Netherlands)
- Novel Antibiotics and Antimicrobial Agents - Antimicrobial Congress 2024 (Czech Republic)
- Novel Antiviral Therapies - Virology-2024 (Canada)
- Novel Vaccine Delivery Methods - Virology-2024 (Canada)
- Obstetric Trauma - TRAUMA 2024 (Netherlands)
- Paediatric Trauma - TRAUMA 2024 (Netherlands)
- Pathogenic Microbes in Immunology and Microbiology - Beneficial Microbes 2024 (Ireland)
- Pathogenic Microbes in Medicine and Dentistry - Beneficial Microbes 2024 (Ireland)
- Pediatric Microbiome [Vaginal Delivery Versus C-Section] - Microbiome 2024 (UK)
- Pharmacogenomics - Microbiome 2024 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Plant Beneficial Microbes - Microbiome 2024 (UK)
- Plant Conditioners [Biostimulants] - Microbiome 2024 (UK)
- Prebiotics and Probiotics - Microbiome 2024 (UK)
- Probiotics & Prebiotics - Beneficial Microbes 2024 (Ireland)
- Psychological Trauma - TRAUMA 2024 (Netherlands)
- Role of microbial communities in the pathogenesis of periodontal diseases and caries (Oral Microbiome) - Microbiome 2024 (UK)
- Signaling in the phytoMicrobiome - Microbiome 2024 (UK)
- Skincare products with probiotics worth the hype - Microbiome 2024 (UK)
- Soil biological management - Beneficial Microbes 2024 (Ireland)
- Strategies for Fungal Infections - Antimicrobial Congress 2024 (Czech Republic)
- Structural and Molecular virology - Virology-2024 (Canada)
- The Dynamic Microbiome - Microbiome 2024 (UK)
- The globalization of cannabis cultivation- A Growing Challenge - Microbiome 2024 (UK)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2024 (UK)
- The role of the Microbiome in cancer development and therapy - Microbiome 2024 (UK)
- The Skin Microbiome - Microbiome 2024 (UK)
- Transmission of Viruses - Virology-2024 (Canada)
- Transplant-Associated Viral Infections - Virology-2024 (Canada)
- Trauma & Critical Care Nursing - TRAUMA 2024 (Netherlands)
- Trauma Emergency Medicine - TRAUMA 2024 (Netherlands)
- Trauma in Nursing & Midwifery - TRAUMA 2024 (Netherlands)
- Trauma Therapy - TRAUMA 2024 (Netherlands)
- Trauma-An International Perspective - TRAUMA 2024 (Netherlands)
- Trauma-Mass Casualties Incidents - TRAUMA 2024 (Netherlands)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2024 (Canada)
- Vaccines and Immunotherapies - Antimicrobial Congress 2024 (Czech Republic)
- Vaccines and the Microbiome - Virology-2024 (Canada)
- Veterinary virology - Virology-2024 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2024 (Canada)
- Viral Immunology and Immunopathology - Virology-2024 (Canada)
- Viral Oncology - Virology-2024 (Canada)
- Viral Pathogenesis - Virology-2024 (Canada)